Theresa Campbell Johnson

Address:

3430 Abbie Pl, Baltimore, MD 21244

VIN:

1D8GU58K17W583550

Make:

DODGE

Model:

NITRO

Year:

2007

Address:

2213 Caronia St APT B, Charlotte, NC 28208

VIN:

KNDJD736975709332

Make:

KIA

Model:

SORE

Year:

2007

Address:

724 W Kingsway Rd, Middle River, MD 21220

Phone:

4107371557

VIN:

KNAGE123075083498

Make:

KIA

Model:

OPTIMA

Year:

2007

US Patent:

H17329, Jun 2, 1998

Filed:

Mar 10, 1994

Appl. No.:

8/212441

Inventors:

Theresa Louise Johnson - Hunt Valley MD

International Classification:

B32B 164

US Classification:

428 68

Abstract:

The present invention provides an article of manufacture which minimizes odor caused by bodily fluids, i. e. perspiration, comprising: a liquid pervious topsheet; a liquid impervious backsheet; an absorbent core positioned between the topsheet and the backsheet; and optionally, a means for supporting the article in an appropriate position to perform its absorbency and odor control function; wherein the topsheet comprises an apertured plastic film containing an effective amount of zeolite impregnated with a heavy metal ion; The articles of the present invention provide an increase in the topsheet surface area available for contact with external body fluids such as perspiration, places the antibacterial active in the closest proximity to the skin of the wearer, the active reducing the perspiration malodor by minimizing its formation.

US Patent:

20220362244, Nov 17, 2022

Filed:

Apr 30, 2021

Appl. No.:

17/245423

Inventors:

- Darmstadt, DE
Roch BOIVIN - Billerica MA, US
Igor MOCHALKIN - Billerica MA, US
Theresa JOHNSON - Billerica MA, US
Nina LINDE - Darmstadt, DE
Doreen MUSCH - Darmstadt, DE
Deepak KUMAR - Billerica MA, US

International Classification:

A61K 31/506
A61K 31/497
A61K 39/395
A61K 45/06
C07D 401/04
C07D 491/107
C07D 513/10

Abstract:

The invention relates to carboxamide-pyrimidine derivatives of the general formula I,or a pharmaceutically acceptable salt thereof, and the use of the compounds of the present invention for the treatment of hyperproliferative diseases and disorders in mammals, especially humans, and pharmaceutical compositions containing such compound.

US Patent:

20210163487, Jun 3, 2021

Filed:

Apr 1, 2019

Appl. No.:

17/046751

Inventors:

- Darmstadt, DE
Nadia BRUGGER - Billerica MA, US
Theresa JOHNSON - Billerica MA, US

International Classification:

C07D 487/04
C07D 495/04
C07D 471/04

Abstract:

The present invention relates to compounds of Formula I and pharmaceutically acceptable compositions thereof, useful as IRAK inhibitors.

US Patent:

20200317622, Oct 8, 2020

Filed:

Apr 8, 2020

Appl. No.:

16/843735

Inventors:

- Darmstadt, DE
Roch Boivin - North Chelmsford MA, US
Theresa Johnson - Salem MA, US
Yanping Wang - Billerica MA, US
Yufang Xiao - Lexington MA, US
Xiaoling Chen - Chestnut Hill MA, US
Nina Linde - Frankfurt AM Main, DE
Doreen Musch - Reinheim, DE
Deepak Kumar - Canton MA, US

International Classification:

C07D 239/36
A61P 35/00
C07D 401/04
C07D 491/107
C07D 491/052
C07D 403/04
C07D 487/10
C07D 239/42
C07D 401/14
C07D 471/10
C07D 491/20

Abstract:

The invention relates to pyrimidinone derivatives of the general Formula I,or a pharmaceutically acceptable salt thereof, and the use of the compounds of the present invention for the treatment of hyperproliferative diseases and disorders in mammals, especially humans, and pharmaceutical compositions containing such compound.

US Patent:

20200281926, Sep 10, 2020

Filed:

Mar 9, 2020

Appl. No.:

16/813192

Inventors:

- Darmstadt, DE
Roch BOIVIN - North Chelmsford MA, US
Igor MOCHALKIN - Westford MA, US
Theresa JOHNSON - Salem MA, US
Nina LINDE - Frankfurt Am Main, DE
Doreen MUSCH - Reinheim, DE
Deepak KUMAR - Canton MA, US

International Classification:

A61K 31/506
A61K 45/06
A61K 39/395
A61K 31/497
C07D 401/04
C07D 491/107
C07D 513/10

Abstract:

The invention relates to carboxamide-pyrimidine derivatives of the general formula I,or a pharmaceutically acceptable salt thereof, and the use of the compounds of the present invention for the treatment of hyperproliferative diseases and disorders in mammals, especially humans, and pharmaceutical compositions containing such compound.

US Patent:

20190233417, Aug 1, 2019

Filed:

Apr 8, 2019

Appl. No.:

16/378383

Inventors:

- Darmstadt, DE
Jeyaprakashnarayanan Seenisamy - Karnataka, IN
Lesley Liu-Bujalski - Bedford MA, US
Richard D. Caldwell - Brookline MA, US
Justin Potnick - Acton MA, US
Hui Qiu - Acton MA, US
Constantin Neagu - Belmont MA, US
Reinaldo Jones - Lowell MA, US
Annie Cho Won - Somerville MA, US
Andreas Goutopoulos - Boston MA, US
Brian A. Sherer - Nashua NH, US
Theresa L. Johnson - Salem MA, US
Anna Gardberg - Arlington MA, US

International Classification:

C07D 471/04
C07D 519/00

Abstract:

Imidazo pyridine compounds, and pharmaceutically acceptable compositions thereof are useful as BTK inhibitors.

US Patent:

20180243324, Aug 30, 2018

Filed:

May 3, 2018

Appl. No.:

15/969907

Inventors:

- Darmstadt, DE
Lesley LIU-BUJALSKI - Bedford MA, US
Reinaldo JONES - Lowell MA, US
Donald BANKSTON - Dracut MA, US
Theresa L. JOHNSON - Salem MA, US
Igor MOCHALKIN - Westford MA, US
Ngan NGUYEN - Arlington MA, US
Hui QIU - Lexington MA, US
Andreas GOUTOPOULOS - Boston MA, US
Nadia BRUGGER - Cambridge MA, US

International Classification:

A61K 31/69
A61K 31/44
A61K 31/5377
A61K 31/55
A61K 31/505
A61K 31/506
A61K 31/4545

Abstract:

The present invention provides novel pyrimidine and pyridine compounds according to Formula (I), Formula (II), Formula (III), Formula (IV) and Formula (V) their manufacture and use for the treatment of hyperproliferative diseases including, but not limited to, cancer, lupus, allergic disorders, Sjogren's disease and rheumatoid arthritis. In preferred embodiments, the present invention describes irreversible kinase inhibitors including, but not limited to, inhibitors of Bruton's tyrosine kinase.

US Patent:

20180237402, Aug 23, 2018

Filed:

Apr 24, 2018

Appl. No.:

15/960759

Inventors:

- Darmstadt, DE
Ruoxi LAN - Waltham MA, US
Justin POTNICK - Acton MA, US
Lizbeth Celeste DESELM - Melrose MA, US
Constantin NEAGU - Belmont MA, US
Xiaoling CHEN - Chestnut Hill MA, US
Roch BOIVIN - North Chelmsford MA, US
Theresa L. JOHNSON - Salem MA, US
Andreas GOUTOPOULOS - Boston MA, US

International Classification:

C07D 253/08
C07D 403/12
C07D 401/12
A61K 31/53
A61K 31/519
C07D 471/04
A61K 45/06

Abstract:

Novel azaquinazoline carboxamide derivatives of formula (I)wherein W, W, W, W, R, R, Rand m which are defined above, are p70S6K inhibitor, and can be employed, inter alia, for the treatment of hyperproliferative disorders.